Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cance... (source: Medical News Today) - RSS news feeds and Widgets on Feedzilla.com
- 1,500 people die of cancer everyday
- 1 in 3 people will develop cancer in their lifetime
- 10% or fewer enroll in a clinical trial while seeking treatment
- 1.5 million newly diagnosed cases of cancer in 2009
Post new comment